JP2024540304A5 - - Google Patents
Info
- Publication number
- JP2024540304A5 JP2024540304A5 JP2024526616A JP2024526616A JP2024540304A5 JP 2024540304 A5 JP2024540304 A5 JP 2024540304A5 JP 2024526616 A JP2024526616 A JP 2024526616A JP 2024526616 A JP2024526616 A JP 2024526616A JP 2024540304 A5 JP2024540304 A5 JP 2024540304A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- day
- administration
- administered
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275157P | 2021-11-03 | 2021-11-03 | |
| US63/275,157 | 2021-11-03 | ||
| US202163280791P | 2021-11-18 | 2021-11-18 | |
| US63/280,791 | 2021-11-18 | ||
| US202163288785P | 2021-12-13 | 2021-12-13 | |
| US63/288,785 | 2021-12-13 | ||
| US202263394726P | 2022-08-03 | 2022-08-03 | |
| US63/394,726 | 2022-08-03 | ||
| PCT/IB2022/060616 WO2023079494A1 (en) | 2021-11-03 | 2022-11-03 | Corticosteriod reduction in treatment with anti-cd38 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540304A JP2024540304A (ja) | 2024-10-31 |
| JP2024540304A5 true JP2024540304A5 (cg-RX-API-DMAC7.html) | 2025-11-11 |
Family
ID=84361138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526616A Pending JP2024540304A (ja) | 2021-11-03 | 2022-11-03 | 抗ｃｄ３８抗体による治療におけるコルチコステロイドの減少 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20230136301A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4426435A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024540304A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240099411A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022380155A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237175A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024001324A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312514A (cg-RX-API-DMAC7.html) |
| JO (1) | JOP20240106A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005406A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023079494A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024360739A1 (en) * | 2023-10-12 | 2026-04-02 | Janssen Biotech, Inc. | Methods for treating multiple myeloma comprising an anti-cd38 antibody combined with bortezomib, lenalidomide and dexamethasone |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| NZ542873A (en) | 2003-03-05 | 2008-07-31 | Halozyme Inc | Soluble, neutral-active hyaluronidase activity glycoprotein (sHASEGP) that is produced with high yield in a mammalian expression system by introducing nucleic acids that lack a narrow region encoding amino acids in the carboxy terminus of the human PH20 cDNA |
| KR20140066259A (ko) | 2004-02-06 | 2014-05-30 | 모르포시스 아게 | 항-ｃｄ３８ 인간 항체 및 그의 용도 |
| JP5225069B2 (ja) | 2005-03-23 | 2013-07-03 | ゲンマブ エー／エス | 多発性骨髄腫の治療のためのｃｄ３８に対する抗体 |
| TW200745162A (en) | 2005-05-24 | 2007-12-16 | Morphosys Ag | Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38 |
| CA2625681C (en) | 2005-10-12 | 2016-08-02 | Morphosys Ag | Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| EP1914242A1 (en) | 2006-10-19 | 2008-04-23 | Sanofi-Aventis | Novel anti-CD38 antibodies for the treatment of cancer |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| AR072999A1 (es) | 2008-08-11 | 2010-10-06 | Medarex Inc | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos |
| UA117901C2 (uk) | 2011-07-06 | 2018-10-25 | Ґенмаб Б.В. | Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування |
| RU2766608C2 (ru) | 2012-04-11 | 2022-03-15 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток |
| BR112015027313A2 (pt) | 2013-04-29 | 2017-09-26 | Teva Pharmaceuticals Australia Pty Ltd | anticorpos anti-cd38 e fusões ao interferon alfa-2b atenuado |
| US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
| ES2878449T3 (es) | 2014-07-24 | 2021-11-18 | 2Seventy Bio Inc | Receptores antigénicos quiméricos de BCMA |
| CN118271463A (zh) | 2014-12-05 | 2024-07-02 | 纪念斯隆-凯特琳癌症中心 | 靶向g-蛋白偶联受体的嵌合抗原受体及其用途 |
| HRP20191873T1 (hr) | 2014-12-12 | 2020-01-24 | Bluebird Bio, Inc. | Kimerni antigenski receptori |
| EA201792546A1 (ru) * | 2015-05-20 | 2018-04-30 | Янссен Байотек, Инк. | Антитела к cd38 для лечения амилоидоза легких цепей и прочих cd38-положительных гематологических злокачественных опухолей |
| CN105384825B (zh) | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| WO2018028647A1 (en) | 2016-08-10 | 2018-02-15 | Legend Biotech Usa Inc. | Chimeric antigen receptors targeting bcma and methods of use thereof |
| MX2018002043A (es) | 2015-08-17 | 2018-07-06 | Janssen Pharmaceutica Nv | ANTICUERPOS ANTI-BCMA, MOLíCULAS DE UNIíN A ANTíGENOS BIESPECíFICAS QUE SE UNEN A BCMA Y CD3, Y USOS DE ESTOS. |
| DE102016211884A1 (de) | 2016-06-30 | 2018-01-04 | Zf Friedrichshafen Ag | Getriebe für ein Kraftfahrzeug, sowie Antriebsstrang für ein Kraftfahrzeug |
| TWI781108B (zh) | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| US20200017600A1 (en) | 2018-07-13 | 2020-01-16 | Genmab A/S | Variants of cd38 antibody and uses thereof |
| KR20210077725A (ko) * | 2018-10-17 | 2021-06-25 | 얀센 바이오테크 인코포레이티드 | 항-cd38 항체의 피하 투여를 제공하는 방법 |
| BR112021013824A2 (pt) | 2019-01-18 | 2021-12-14 | Janssen Biotech Inc | Receptores de antígeno quiméricos gprc5d e células que expressam os mesmos |
| US20200308297A1 (en) * | 2019-03-28 | 2020-10-01 | Janssen Biotech, Inc. | Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses |
-
2022
- 2022-11-03 AU AU2022380155A patent/AU2022380155A1/en active Pending
- 2022-11-03 US US17/979,874 patent/US20230136301A1/en not_active Abandoned
- 2022-11-03 US US17/980,149 patent/US20230134748A1/en active Pending
- 2022-11-03 JP JP2024526616A patent/JP2024540304A/ja active Pending
- 2022-11-03 CA CA3237175A patent/CA3237175A1/en active Pending
- 2022-11-03 WO PCT/IB2022/060616 patent/WO2023079494A1/en not_active Ceased
- 2022-11-03 KR KR1020247018523A patent/KR20240099411A/ko active Pending
- 2022-11-03 EP EP22809519.6A patent/EP4426435A1/en active Pending
- 2022-11-03 MX MX2024005406A patent/MX2024005406A/es unknown
- 2022-11-03 IL IL312514A patent/IL312514A/en unknown
-
2024
- 2024-04-30 CL CL2024001324A patent/CL2024001324A1/es unknown
- 2024-05-01 JO JOJO/P/2024/0106A patent/JOP20240106A1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102811730B (zh) | 孕激素作为糖皮质激素增敏剂的使用 | |
| JP2025102775A5 (cg-RX-API-DMAC7.html) | ||
| JP2021534201A5 (cg-RX-API-DMAC7.html) | ||
| JP2022538237A5 (cg-RX-API-DMAC7.html) | ||
| Marrani et al. | Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series | |
| Rasheed et al. | A review of natural steroids and their applications | |
| JP2024518947A5 (cg-RX-API-DMAC7.html) | ||
| JP2024129140A5 (cg-RX-API-DMAC7.html) | ||
| JP2019514974A5 (cg-RX-API-DMAC7.html) | ||
| JP2024540304A5 (cg-RX-API-DMAC7.html) | ||
| Jiang et al. | Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus | |
| JP2025072466A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2020250915A5 (cg-RX-API-DMAC7.html) | ||
| Helfer et al. | Corticosteroids and adrenal suppression: characterising and avoiding the problem | |
| JP2024537288A5 (cg-RX-API-DMAC7.html) | ||
| US6096731A (en) | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation | |
| JP2022537555A5 (cg-RX-API-DMAC7.html) | ||
| JP2024543509A5 (cg-RX-API-DMAC7.html) | ||
| IL312514A (en) | Corticosteroid reduction in treatment with anti-cd38 antibodies | |
| IL312515A (en) | Bispecific cd16a binders | |
| Sandborn | Steroid‐Dependent Crohn’s Disease | |
| Myers | Treatment of multiple sclerosis with ACTH and corticosteroids | |
| WO2020106191A1 (ru) | Производное глутаримида для преодоления резистентности к стероидам | |
| JP2024516886A5 (cg-RX-API-DMAC7.html) | ||
| JP2021505545A5 (cg-RX-API-DMAC7.html) |